Evidence check

Garcinia Cambogia: What The JAMA Trial Actually Found

Garcinia is in almost every appetite formula on the market on the strength of a mechanism that works in a test tube. The most direct test of that idea in people was published in JAMA in 1998, ran for twelve weeks at 1,500 mg a day, and found nothing.

By SodaSlim Team · Last updated November 4, 2026 · 9 min read · Evidence check · Reviewed by Dr. Sharon Montes, MD

The trial that tested the idea directly

The 1998 trial is unusually well designed for this category. It enrolled 135 overweight adults, randomised them to 1,500 milligrams of hydroxycitric acid a day or to placebo, ran for twelve weeks, and put everyone on the same high-fibre, low-energy diet so the capsule was the only variable.

Both groups lost weight, because both groups were dieting. The groups did not differ in fat mass, which was the outcome the trial was built to detect.

That is about as clean a negative result as a supplement ingredient gets. The dose was generous, the trial was long enough, the sample was reasonable and the diet was controlled.

Every row is a human study. The mechanism claim comes from test-tube work, which is covered further down.

A 2011 meta-analysis of the trials available at the time did find a small difference in weight in favour of the ingredient, and the authors were careful about it: they described the effect as of questionable clinical relevance given the quality of the underlying studies. A meta-analysis is only as good as what it pools.

Where the mechanism claim comes from

Almost every sales page for garcinia describes it as blocking the enzyme the body uses to make fat. That sentence is accurate about a test tube and it is doing a great deal of work it has not earned.

Hydroxycitric acid does inhibit ATP citrate lyase, an enzyme in the pathway that converts excess carbohydrate into fatty acids. What that sentence leaves out is that in people eating an ordinary mixed diet, this pathway is not a major route to stored fat in the first place. Most stored fat arrives as fat.

So the enzyme can be inhibited exactly as described and very little follows from it. That is not a trick. It is the ordinary gap between a mechanism and an outcome, and it is the reason trials exist.

A mechanism is a reason to run a trial. It is not a substitute for one.

The appetite question, asked separately

Garcinia is usually sold for appetite rather than for the enzyme, so the question was asked directly.

Mattes and Bormann tested hydroxycitric acid against appetitive variables in people: hunger ratings, fullness, and how much food was actually eaten. They found no effect on any of them.

That is worth setting beside the four support lines this kind of bottle carries. Two of them are about craving control and satiety, and the ingredient that half of the formula rests on has been tested for exactly that and came back empty.

Some people taking this kind of capsule do report an easier afternoon. That report is real and it is not the same as a demonstrated effect, and a good page says both things rather than choosing one.

Why the dose in a capsule matters here

The 1998 trial used 1,500 mg of hydroxycitric acid a day. Most multi-ingredient capsules carry a small fraction of that once the garcinia extract's standardisation is taken into account.

That creates an odd situation. The negative result from the trial does not straightforwardly apply to a capsule containing a tenth of the dose, because that is a different exposure that nobody has tested. A supporter of the ingredient could fairly say the trial does not rule out the capsule.

The trouble with that defence is that it cuts the other way with more force. If the dose the trials used produced nothing, a tenth of it producing something would be surprising. And on a label that prints no amount at all, neither argument can be checked.

• Look for hydroxycitric acid, not just garcinia. The extract is standardised to a percentage of it, usually 50 or 60 per cent.
• Do the arithmetic. A 500 mg garcinia extract at 60 per cent is 300 mg of hydroxycitric acid, which is a fifth of the trial dose.
• Treat a missing figure as a missing figure. It is not evidence of a low dose, and it is not evidence of a high one.
• Do not pay a premium for it. Garcinia is cheap, and it is in most of these formulas because it is familiar rather than because it works.

The safety literature

A review of safety and efficacy in humans covers both sides of the ingredient, and the safety side is worth knowing even though the events involved are rare.

A case series and literature review collected reports of acute liver injury following garcinia weight-loss supplementation, and a 2019 case report describes one in detail. Most reports involve multi-ingredient products, which makes attribution difficult, and the mechanism is not established.

Keeping this in proportion matters. Garcinia is taken by very large numbers of people and reported liver events number in the dozens rather than the thousands. The reason to name them is that they are recognisable: yellowing skin or eyes, dark urine, pain under the right ribs, persistent nausea or unexplained tiredness. Somebody who recognises those stops a week earlier than somebody who does not.

Why garcinia is still in almost every formula

Given all of the above, the obvious question is why the ingredient remains so common. There are three reasons and none of them is about evidence.

It is cheap. Garcinia extract costs very little per capsule, which matters when a formula has to carry five names and hit a price point. It is familiar: a buyer scanning a label recognises it, and recognition sells. And it has a story that fits in one sentence, which is the most valuable property an ingredient can have on a sales page.

None of that makes its inclusion dishonest. A formula is allowed to contain an ingredient with a weak evidence base as long as the label does not claim more than the evidence supports. The problem arises where a sales page describes it as blocking the body's fat production, which is a claim about a person rather than about a test tube.

That distinction is the reason this desk declined to carry that sentence. The refusal is recorded with its reason, which is more useful than silently leaving it out.

References